Trade-Ideas LLC identified

Vascular Solutions

(

VASC

) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Vascular Solutions as such a stock due to the following factors:

  • VASC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $4.1 million.
  • VASC has traded 92,424 shares today.
  • VASC is trading at 8.12 times the normal volume for the stock at this time of day.
  • VASC is trading at a new high 5.01% above yesterday's close.

'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in VASC with the Ticky from Trade-Ideas. See the FREE profile for VASC NOW at Trade-Ideas

More details on VASC:

TheStreet Recommends

Vascular Solutions, Inc., a medical device company, provides clinical solutions for treating coronary and peripheral vascular disease worldwide. VASC has a PE ratio of 54. Currently there are 2 analysts that rate Vascular Solutions a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Vascular Solutions has been 128,700 shares per day over the past 30 days. Vascular has a market cap of $539.8 million and is part of the health care sector and health services industry. The stock has a beta of 1.01 and a short float of 3.5% with 4.52 days to cover. Shares are down 9.6% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Vascular Solutions as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow.

Highlights from the ratings report include:

  • VASC's revenue growth trails the industry average of 29.6%. Since the same quarter one year prior, revenues rose by 13.4%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • VASC has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 3.64, which clearly demonstrates the ability to cover short-term cash needs.
  • The gross profit margin for VASCULAR SOLUTIONS INC is rather high; currently it is at 68.11%. It has increased from the same quarter the previous year. Despite the strong results of the gross profit margin, VASC's net profit margin of 4.08% significantly trails the industry average.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. When compared to other companies in the Health Care Equipment & Supplies industry and the overall market, VASCULAR SOLUTIONS INC's return on equity is below that of both the industry average and the S&P 500.
  • Net operating cash flow has decreased to $2.58 million or 20.00% when compared to the same quarter last year. In addition, when comparing the cash generation rate to the industry average, the firm's growth is significantly lower.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.